Correction

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial (vol 14, 1510, 2022)

Journal

CANCERS
Volume 15, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/cancers15051485

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available